A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05521802 · RECRUITING
Trial details
- NCT number
- NCT05521802
- Sponsor
- Shanghai AbelZeta Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-11
- Primary completion
- 2024-07-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.